Print

IAVI C001

A Randomized, Placebo-Controlled, Dose-Escalating, Double-Blinded Phase 1 Study to Evaluate the Safety and Immunogenicity of a Clade C DNA Vaccine ADVAX e/g + ADVAX p/n-t (ADVAX) Administered Intramuscularly to HIV-Uninfected, Healthy Volunteers

Trial Details:

I Completed
Aaron Diamond AIDS Research Center, International AIDS Vaccine Initiative (IAVI) December 01, 2003
ADVAX Nef, Gag, Env, Tat, Pol C
ADVAX DNA
USA 45
NCT00249106
https://clinicaltrials.gov/ct2/show/NCT00249106?term=%22IAVI+C001%22&rank=1